Clinical Trials Browser

Phase 1 × Lung Cancer Metastatic × osimertinib × Clear all

NCT04085315 2024-06-10

Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Phase 1 Recruiting

Lung Cancer Metastatic